On January 14, the Department of Justice (DOJ) announced that five Kaiser Permanente affiliates agreed to pay $556 million to resolve allegations that they violated the False Claims Act (FCA) by submitting unsupported diagnosis codes for Medicare Advantage (MA) beneficiaries to increase reimbursement from the federal government. The relators will receive approximately $95 million as their share of
Day 3 Notes from the 44th Annual J.P. Morgan Healthcare Conference
I have to admit to an instinctive gut reaction of skepticism when Kimberly Powell of NVIDIA on Monday said that “AI is a once-in-a-lifetime shift for the healthcare industry.” Intellectually, I am excited by AI and its possibilities, but I well know healthcare’s slow and steady approach and rigid workflows can chew up technology gains
HHS Proposes Changes to the Health IT Certification Program and Information Blocking Regulations in HTI-5 Proposed Rule
On December 29, 2025, the U.S. Department of Health and Human Services (“HHS”), through the Assistant Secretary for Technology Policy (“ASTP”)/Office of the National Coordinator for Health Information Technology (“ONC”) (collectively, “ASTP/ONC”), issued a proposed rule to update its Health Data, Technology, and Interoperability (“HTI”) regulations, as well as a notice to withdraw prior proposals
Day 2 Notes from the 44th Annual J.P. Morgan Healthcare Conference
J.P. Morgan continues to surprise us at lunch, with the Mayor of San Francisco sharing on Monday an update on recent improvements in the city. Then on Tuesday at the Grand Ballroom lunch, it was the first episode of my favorite new sit-com “Everyone but Abe…”
Notes from Day 1 of the 44th Annual J.P. Morgan Healthcare Conference
At the 44th Annual J.P. Morgan Healthcare Conference, Jamie Dimon (CEO of J.P. Morgan) told the audience that we should be teaching healthcare in school from kindergarten to 12th grade. He was right…but we don’t. And, therefore, artificial intelligence will come to dominate the U.S. healthcare system, which spent over $5.6 trillion in 2025. Wait, you might say,
HIPAA Compliance in Remote NP-Physician Collaboration: A 2026 Guide
Remote collaboration between nurse practitioners (NPs) and physicians is now a core part of modern care delivery—especially in telehealth-forward practices, rural coverage models, and multi-site organizations. But with that flexibility comes heightened risk: more devices, more endpoints, more messages, and more chances to mishandle protected health information (PHI).
This 2026 guide breaks down practical steps
5 Developments Digital Health Innovators Should Watch in 2026
With 2026 underway, signs point to another year focused on enhancing health IT and digital health innovation. From new payment models to deregulatory efforts, these developments show that digital health continues to be increasingly central to the healthcare and life sciences sectors. Below are five key developments to watch unfold in the year ahead.
New Year, New AI Rules: Healthcare AI Laws Now in Effect
As healthcare organizations ring in 2026, they will also be ringing in a new era of AI regulation. With Congress yet to pass comprehensive AI legislation and federal regulatory guidance in flux, states have stepped in to fill the void. The new year will see several new laws imposing disclosure, transparency, and data protection requirements
HTI-5 and Information Blocking: Your Bots Are Covered, and Your Excuses Are Getting Smaller
If you have been telling yourself, “Information blocking only happens when a person says ‘no’,” HTI-5 has some news for you. The proposed rule makes a pointed set of changes to the information blocking framework that, taken together, do two things at once. First, they modernize the rules for how EHI moves in 2026 (hello,
Navigating Clinical Practice with the CDC Advisory Committee on Immunization Practices’ Updated Hepatitis B Recommendation for Newborns
The Centers for Disease Control and Prevention (“CDC”) Advisory Committee on Immunization Practices (“ACIP”) develops recommendations for how vaccinations are used to control disease in the United States. Earlier this month, the ACIP voted 8-3 to narrow the CDC’s guidance on newborn hepatitis B vaccination administration. Hepatitis B is an infection that causes inflammation in the